A new paper, published just yesterday.
The abstract on this is interesting, especially the influence of formaldehyde at neutral and higher pH levels.
I shall be getting the full copy to digest.
A new paper, published just yesterday.
The abstract on this is interesting, especially the influence of formaldehyde at neutral and higher pH levels.
I shall be getting the full copy to digest.
Interesting paper.
The abstract is aligned with some of the principles on this summarized by EMA in an open access paper (equally citing the original Casado work):
Formation of N-Nitrosamine Drug Substance Related Impurities in Medicines: A Regulatory Perspective on Risk Factors and Mitigation Strategies | Organic Process Research & Development (acs.org)
Historically we had to assess when and if formaldehyde (ppm level LOD/LOQ) testing on medicines was critical to exclude this possible (dominant) root cause (as described in the EMA paper) in nitrosamine pre-testing and post-testing, anyone having to do the same will benefit from buying the paper.
An interesting follow on from this - well worth the hour of your time to watch in my opinion - has given me some areas to ponder.
Very interesting, indeed! Thanks for sharing!